eli lilly tirzepatide pill lilly's is the leader in weight loss sector Lilly, maker of Zepbound and Mounjaro FDA Approves Lilly's Zepbound™ (tirzepatide)

However, employers increasingly want coverage included in their plans

There are clear opportunities for further research with MT1 to examine clinically significant endpoints, such as quality of life, reduced pain, and improved mood in patients afflicted by various skin and light-sensitivity conditions

There are no studies and no evidence as to the efficacy [of] microdosing, therefore I am unaware of any benefits

Seven additional Phase 3 TRIUMPH trials are expected to report results throughout 2026, covering obesity, type 2 diabetes, sleep apnea, chronic low back pain, and metabolic liver disease (ClinicalTrials.gov)